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INTRODUCTION 
Leukemia is the most common cancer among children in world. 
It is the commonest cause of mortality and morbidity among all 
cancers. Among all causes infection is the most common cause of 
mortality and morbidity among leukemic patients. 
 
Statement of problem and need of the study 
 As with any immune compromised child, leukemic children are 
more prone for various types  of infections. It is an universal problem 
even in developed nations with highly sterilized aseptic wards.  Hence, 
this being an important problem, I had decided to take up this study of 
analysing the common organisms and their sensitivity in leukemic 
patients. 
 
Leukemic patients experience recurrent febrile episodes during 
the course of their disease. This is because leukemic patients are more 
prone for recurrent opportunistic infections due to immunosuppression 
and neutropenia caused by chemotheraphy and the disease per se1. But 
only limited data is available regarding the changing pattern of 
infections and their sensitivity to antibiotics from South Tamilnadu.  
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The present study, therefore, was planned to study the infections 
in leukemia patients with reference to the causative organism and the 
culture sensitivity pattern of these organisms at the INSTITUTE OF 
CHILD HEALTH, MADURAI for a period of TWO years. 
Leukemia  
It is defined as the group of malignant diseases in which genetic 
abnormalities in a hemotopoietic cell gives rise to a clonal proliferation 
of cells resulting in disruption of normal marrow function and 
ultimately marrow failure2. Healthy bone marrow makes blood cells 
that stop bleeding and fight infections. In leukemia, bone marrow 
makes abnormal blood cells that are unable to do this critical job. 
Symptoms of Leukemia 
Initial presentation of ALL is usually non specific. Anorexia, 
fatigue, irritability, intermittent fever are initial symptoms. Bone / joint 
pain may be present. As the disease progress signs of bone marrow 
failure like pallor, fatigue, bruising (or) epistatis as well as fever which 
may be caused by infections appear3.  
On examination pallor, listlessness, purpura, petechial skin 
lesions (or) mucus membrane hemorrhage may occur. The proliferative 
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nature of leukemia manifests as lymphadenopathy, splenomegaly and 
hepatomegaly4.  
Types of leukemia 
Acute Lymphoblastic Leukemia is the most common type of 
leukemia in children (77%). Next is Acute Myelogenous Leukemia 
which is about 11% followed by chronic myelogenous leukemia (3-
5%). Rest of 7-9% cases include a variety of acute and chronic cases 
that do not fit classic definitions of above5.   
Leukemia is commonly treated with chemotheraphy and 
radiotheraphy. 
Frequent infections in leukemia 
Leukemia can make the body extremely vulnerable to infection, 
which may seem confusing because of increased numbers of white 
blood cells. Unfortunately, the abnormal white blood cells that are 
produced do not have the ability to effectively fight against infections 
and there are not usually enough healthy white blood cells to keep the 
immune system strong. In the post chemotherapy scenario where the 
patients are in a state of bone marrow depression they are also 
vulnerable to infections due to neutropenia.   
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Fever is one response of the immune system to infections and 
are caused by the release of chemicals that tell the brain to raise the 
body's temperature. When a person has leukemia, these chemicals may 
be released excessively, causing frequent or persistent fevers mostly 
caused by infections. 
Although fever can be induced by other causes such as blood 
products, drugs or thrombophlebitis, fever in neutropenic host must be 
considered as a potential sign of infection. The infections caused by 
bacteria, viruses, fungi and parasites are the common cause of 
morbidity and mortality.  
It has been pointed out for more than 30 years that the risk of 
infection increases with the ‘degree and duration of neutropenia’. 
Cytotoxic regimens used for malignancies may produce neutropenic 
episodes (ANC < 0.5 x log/l) of either short duration, i.e. less than            
7 - 10 days, or more prolonged (2-3weeks). Infections of skin, soft 
tissue G1 tract, bacteremia are more common in leukemics. The natural 
commensals can invade the host to produce symptoms due to 
immunocompromised state.  Cytotoxic drugs preferentially affects 
myeloid cells and are the common cause of neutropenia. Its incidence 
increases with age of the patient. 
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Neutropenia  
It is defined as an absolute neutrophil count (ANC) of less than 
1500/µL. The ANC is equal to the product of the white blood cell 
count (WBC) and the percentage of polymorphonuclear cells (PMNs) 
and band forms noted on the differential analysis: 
ANC  =  WBC (cells/µL)  x  percent (PMNs  +  bands)  ÷  100 
Neutrophilic metamyelocytes and younger forms are not 
included in this calculation. The risk of infection begins to increase at 
an ANC below 1000/µL. 
Neutropenia, is a hematological disorder characterized by an 
abnormally low number of neutrophils, the most important type 
of white blood cell, in the blood. Neutrophils usually make up 50-70% 
of circulating white blood cells and serve as the primary defense 
against infections by destroying bacteria in the blood. Hence, patients 
with neutropenia are more susceptible to bacterial infections and, 
without prompt medical attention, the condition may become life-
threatening (neutropenic sepsis). 
Neutropenia can be acute or chronic depending on the duration 
of the illness. A patient has chronic neutropenia if the condition lasts 
for longer than 3 months. Some common symptoms of neutropenia 
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include fever  and frequent infections. These infections can result in 
conditions such as mouth ulcers, diarrhoea, a burning sensation when 
urinating, unusual redness, pain, or swelling around a wound, or a sore 
throat. 
A complete blood count (CBC), detects neutropenia. 
Fortunately, neutropenia is easily prevented or reduced by granulocyte 
– colony stimulating factor (pegfilgrastim or filgrastim, the short-
acting form). These medications help to produce more white blood 
cells and prevent the complications of neutropenia. 
It is given with the first cycle of chemotherapy after 15 days of 
starting the chemotheraphy and then with each remaining 
chemotherapy cycle. This can reduce the risk of infection (neutropenia 
with fever) by more than 90 percent. 
Candidiasis, invasive fungal infections [aspergillosis] and viral 
infections [herpes] are common in leukemics. They are empirically 
treated with fluconazole, amphotericin and acyclovir respectively. 
An opportunistic infection is an infection caused 
by pathogens (bacterial, viral, fungal or protozoal) that usually do not 
cause disease in a healthy host, i.e. one with a healthy immune system. 
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A compromised immune system, however, presents an "opportunity" 
for the pathogen to infect. 
Approach for the diagnosis of infection  
1. Sample/ swab was obtained  
2. The specimen is gram-stained. The shape, size, arrangement and 
whether they are gram-positive or gram-negative should be 
observed. 
3. The specimen is cultured on appropriate media, to obtain ‘pure 
culture’. Plates should be incubated in aerobic or anaerobic 
environment. 
4. Perform antibiotic susceptibility tests. 
Blood culture 
A minimum of 1:10 of blood: culture is taken 
through venipuncture and injected into two or more bottles with 
specific media for aerobic organisms. 
The blood is collected using clean technique. This requires that 
both the tops of the culture bottles and the venepuncture site of the 
patient are cleaned prior to collection. Microbiological cultures 
utilize petri dishes of differing sizes that have a thin layer of agar based 
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growth medium in them. Once the growth medium in the petri dish is 
inoculated with the desired bacteria, the plates are incubated in an oven 
usually set at 37 degrees Celsius.  
Another method of bacterial culture is liquid culture, in which 
case desired bacteria are suspended in liquid broth, a nutrient medium. 
These are ideal for preparation of an antimicrobial assay. The 
experimenter would inoculate liquid broth with bacteria and let it grow 
overnight in a shaker for uniform growth, then take aliquots of the 
sample to test for the antimicrobial activity of a specific drug or protein 
(antimicrobial peptides). 
 
Procedure for throat swab collection  
1. With the patient’s head tilted back and the throat well illuminated, 
depress the tongue so that the back of the throat can be seen.  
2. Rub the swab up and down the back of the throat and against any 
white patches in the tonsillar area. Avoid the tongue and the cheeks.  
3. Replace the swab in the transport tube.   
4. Seal tube tightly and Send the specimen to the laboratory   
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Skin wound swab collection  
1. Using sterile gloves, thoroughly rinse the wound with normal 
saline to irrigate the excess debris and dirt.  
2. Gently blot excess saline with sterile gauze.  
3. After hand wash and sanitizing, use next pair of gloves and 
gently rotate the top of swab in wound without touching the 
edges.  
4. Apply little pressure to get tissue fluid and put the swab in 
transport container and send it to laboratory.    
Culture Media 
A substance, either solid or liquid, used for 
the cultivation, isolation, identification, or storage of microorganisms. 
A culture is any growth or cultivation of microorganisms. 
Cultivation is the process of inducing microbe to grow. The term 
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culture is usually employed for a deliberate growth in the laboratory. 
Microbes are thus cultivated in vitro. 
A pure culture is one that contains only a single kind (species) 
of microbe. To culture microbes in laboratory we require the 
preparation of substances which they can use as nutrients. Such 
nutrient preparations which microorganisms can use for growth are 
called culture media. Different microorganisms require different 
nutrient materials. Thus culture media vary in form and composition, 
depending on the species to be cultivated. 
There are three main types of culture media: (i) Natural or 
empirical culture media, (ii) Synthetic or defined culture media, and 
(iii) Living media. 
About 70% of all deaths in acute leukemic cases are attributed to 
infections3,11. Moreover, there is a change in pattern of opportunistic 
infections in recent years4-5,13-15. There are few reports on this aspect 
from different hospitals of India5,15-18. 
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REVIEW OF LITERATURE 
 Infections in immune compromised patients like Leukemia is a 
major cause of mortality. Various micro organisms contribute to 
infection as host immunity is suppressed. 
 A similar study done by Gopalanath et al in Banaras Hindu 
University, Varanasi revealed a wide spectrum of infections in patients 
with absolute neutrophil count <5001. 
 Leukemic patients are more prone to infections with pyogenic 
bacteria like pneumococci, streptococci, meningococci, pseudomonas 
and H.influenza2,30. 
 Also gram negative septicaemia is more common leading to 
septic shock. These group can be differentiated into lactose fermenters, 
(commensals) and non-fermenters (pathogenic) by Mcconkey 
medium3-4,31. 
 Staphylococus and pseudomonas infection are severe and 
resistant to commonly used antibiotics4,32. 
 Staphylococus can be coagulase positive (S.Aureus) or 
coagulase negative (S.epidermidis, S.hemolyticus, S.Saprophyticus)5,33. 
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 Caselli et al6 in his study concluded pseudomonas resistance in 
immunocompromised undergoing chemotherapy as a major threat, 
which leads to increased mortality.  
 In a Pakistan study the most common opportunistic infections in 
leukemia are Tuberculosis, Candidiasis, Herpes zoster, hepatitis 
viruses, CMV, cryptococus etc7.  
 Shawn Lockhart et al23 concluded that pseudomonas aeruginosa, 
E.coli and klebsiella are the predominant organisms and imipenem as 
the single most effective antibiotic against them.  
 Novakova et al reported ceftazidime and imipenem for empirical 
treatment of febrile neutropenic patients24.  
 Ashour et al study shows CONS and St.aureus as the most 
common gram positive bacteria25.    
Gram-positive pathogens have become a common cause of 
bacteraemia in granulocytopenic cancer patients. This has been 
partially attributed to the use of central intravenous devices such as 
Hickman catheters; mucositis secondary to intensive antineoplastic 
chemotherapy or herpes infections may also be the source, especially 
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for streptococci, whereas the skin is most probably the source 
for Staphylococcus epidermidis.  
Antimicrobial prophylaxis recommended mainly with the aim of 
reducing the incidence of Gram-negative bacillary infections may also 
play a significant role. The rate of response of documented infections 
caused by Gram-positive cocci to ‘standard’ empirical therapy (which 
has been mainly directed against Gram-negative bacilli) has been 
unsatisfactory although the lethality reported has been low. These 
results raise an important question, whether or not a specific anti-
Gram-positive antibiotic such as vancomycin, should be added to the 
empirical regimen8.   
Viscoli et al8 described the increased incidence of such gram 
positive infections in leukemics.  
Young et al19 concluded that cotrimoxazole prophylaxis decrease 
prevalence of most bacterial infections.  
Maxwell Finland10 et al in his study also emphasised the changes 
patterns of susceptibly of common bacterial pathogens to antimicrobial 
agents in leukemics.  
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Hartstein et al21 even compared the antimicrobial susceptibility 
with plasmid profile analysis as identity tests.    
Nosocomial infections pose significant threats to hospitalized 
patients, especially the immunocompromised ones, such as cancer 
patients. Ashour and Sheriff25 in his study examined the 
microbial spectrum of gram-negative bacteria in various infection 
sites in patients with leukemia . The antimicrobial resistance patterns of 
the isolated bacteria were studied.The most frequently isolated gram-
negative bacteria were Klebsiella pneumonia(31.2%) followed 
by Escherichia coli (22.2%). 
Surveillance study  by Liang et al28 showed that significantly 
fewer bacterial stains were resistant to ofloxacin than to co-trimoxazole 
and that acquisition of resistance to co-trimoxazole was more 
commonly observed than was acquisition of resistance to ofloxacin. 
Significantly more patients had skin rashes following co-trimoxazole 
than ofloxacin treatment (P less than 0.05). Ofloxacin was superior to 
co-trimoxazole in preventing infection in this population of neutropenic 
patients. 
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Incidence of fungal infections were lower in leukemics in Indian 
studies15-18,20 but Choi21 and Riberio22 reported significant detectable 
rates abroad. 
Infections commonly associated with neutropenia are bacterial 
(gram negative sepsis, pertusis, typhoid fever, disseminated 
tuberculosis, brucellosis), viral (measles, rubella, mumps, varicella, 
EBV, influenza, viral hepatitis, RSV, cytomegalovirus, HIV) protozoal 
(malaria, Leishmaniasis) fungal (Histoplasmosis) and rickettial. 
Bone marrow infiltration with leukemic cells results in 
suppression of myelopoiesis loading to pancytopenia and leucocytosis 
in peripheral blood smear. 
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AIM OF THE STUDY 
 
1. To Study the bacteriological profile (incidence of common 
bacterial pathogens) in leukemic children 
2. To analyse the common antibiotic sensitivity patterns for 
these isolated organisms. 
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MATERIALS AND METHODS 
 
This was a hospital based observational prospective study conducted in 
all leukemic children admitted in paediatric Hemato oncology ward, 
GRH, Madurai for a period of 2years (Oct 2008 to Oct 2010)  
 
Settings : 
 This study is conducted in pediatric hematooncology ward in 
collaboration with the Department of Microbiology, GRH, Madurai.   
Ethical Committee : Ethical clearance obtained from ethical 
committee Government Rajaji Hospital, Madurai. 
 
Study Design : observational and analytical   
 
Study Period : 2 Years 
 
Inclusion Criteria : 
 All newly diagnosed and old cases of leukemic on chemotherapy 
<12years with symptoms / signs of infection admitted in Rajaji 
Hospital, Madurai 
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Methodology: 
Data regarding the sex, age, symptoms, clinical profile, lab 
parameters, culture reports, antibiotic sensitivity were collected. 
 
Febrile subjects were investigated for haemoglobin and counts 
of total leukocyte (TLC), differential leucocyte (DLC), platelet, 
absolute neutrophil (ANC). Swabs were taken from skin, oral cavity, 
nasal mucosa,  catheter tips, venflon sites, throat, external ear etc. 
Blood, pus, urine, stool and CSF specimens were taken as per 
indication under full aseptic precautions.  The specimens were 
processed by direct inoculation as well as enrichment on appropriate 
media. 
Special care was taken in collecting blood sample for culture. 
The area to be pricked was thoroughly cleaned with spirit and 
povidone iodine. Sterile disposable syringes were used. The sample 
was then transferred to glucose broth media (1ml blood in 10ml 
media). After incubating for 24 hours at 370C the sample was 
transferred into nutrient agar and McConkey media.  
The organisms were allowed to grow in the plate at 370C for 24 
hours. After further processing of the colonies, the culture was 
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reported, results were obtained after 48 hours, sometime after 72 hours. 
Culture was reported as negative if there was no growth after 48 hours.  
Samples were taken from every possible source of infection in 
febrile cases like blood, urine, throat pus & motion. A study of the 
sensitivity pattern of the organisms isolated to the drugs commonly 
available in our hospital was also conducted. The sensitivity pattern to 
ampicillin (AMP), gentamicin (GM), cotrimoxazole (CO), 
ciprofloxacin (CIP), cefotaxime (CEF), amikacin (AMIK), ceftriaxone 
(CEFTRI), doxycycline (DO) were reported.  
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RESULTS AND ANALYSIS 
The results were analysed based on the culture reports and their 
sensitivity patterns. The commonest organisms isolated from these 
patients were identified from individual sites. 
The total number of samples analysed for culture were 268. 
Blood (114) and urine (98) constitutes the major bulk of samples.  
Pus, throat, motion and CSF constitute the remaining samples.  
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BLOOD CULTURE AND ANTIBIOTICS SENSITIVITY  
Total Number of Positive Samples – 70 Samples 
ORGANISMS  AMP GM DO CIP CEF NOR  CLOX CEPH CEFTRI AMIK 
CONS[34]  5 20 7 24 12 2 29 11 27 21 
ECOLI[3]   1  3  2   3 3 
KLEBSIELLA[5]   2  2 1   1 1 3 
NFGNB(9)   3  4  1   1 6 
ST.AUREUS[10]   1  4 1 1 6 1 1 3 
PSEUDOMONAS[6]   2  3   2   4 
COLIFORMS[1]   1    1   1 1 
ENTEROCOCCUS[1]    1     1 1 
STAPH.ALBUS  1    1  1    
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Bacteriological profile of blood culture  
 CONS (34/70) was the commonest organism isolated from blood 
accounting for about 48.51% of positive culture. 
 Staphylococcus aureus (10/70) is the next common organism 
accounting for 14.27% of total positive cases. 
NFGNB (9/70) accounts for 12.85% of positive samples.  E.coli 
and klebsiella accounted for 10% of cases.  
Other organisms grown were coliforms, enterococcus and 
staphylococcus albus. 
Antibiotic sensitivity pattern 
In blood culture CONS which was the predominant organism 
grown in blood culture was found to be susceptible to cloxacillin in 
85.29% (29/34) of cases followed by ceftriaxone [79.4%] (27/34) and 
ciprofloxacin [70.59%] (24/34). Aminoglycosides (GM, amikacin) was 
sensitive in 60% (20/34) of cases.  
Staphylococcus aureus was susceptible to cloxacillin in 60% of 
cases followed by ciprofloxacin (40%) and amikacin (30%).  
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NFGNB is highly sensitive to amikacin (66%) followed by 
ciprofloxacin (45%) and gentamicin (34%). 
Pseudomonas- Amikacin was the most effective antibiotic (66%) 
followed by ciprofloxacin (50%) gentamicin (33%) and cloxacillin 
(33%).   Klebsiella – Amikacin is effective in 60% of cases followed 
by ciprofloxacin 40% and gentamicin 40%.  
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URINE CULTURE - Distribution of Organisms and their Sensitivity. Total Positive – 70 Samples  
 
 
 
 
 
 
ORGANISMS  AMP GM CO CIP CEF NOR  CLOX CEPH CEFTRI AMIK 
CONS[4]  1 2  3  1 2  2 2 
ECOLI[27]  1 18 3 23 4 8 1 2 14 20 
KLEBSIELLA[22]  1 15 4 19 2 5 2 3 4 17 
NFGNB[11]   2 2 7 2 6  1 3 8 
COLIFORMS[2]   1       1 1 
ENTEROCOCCUS[1]          1 
CITROBACTER[3]   2  1  1   1 2 
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 E.coli is the predominant organism grown in urine culture 
38.57% (27/70). It is sensitive to ciprofloxacin 85.18% (23/27) 
followed by amikacin 74.07% (20/27), ceftriaxone 51.85%  and 
gentamicin 66.6%.  
 Klebsiella is an equally common organism causing UTI (31.2%). 
It is sensitive to ciprofloxacin (86.36%) followed by amikacin 
(77.27%) and gentamicin (68.18%).    
NFGNB is the next common organism (15.71%).  It is relatively 
resistant bacteria compared to other organisms grown in urine culture. 
It is sensitive to amikacin (72.72%), ciprofloxacin (63.63%) and 
norfloxacin (54.54%).  
CONS, Citrobacter, coliforms and enterococcus are the other 
organisms grown in urine culture.      
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THROAT SWAB CULTURE AND SENSITIVITY  
Total number of positive culture – 23 Samples 
 
 
 
 
 
 
 
 
 
 
Organisms AMP  GM  DOXY CIP CEF  NOR  CLOX ERY  CEFTRI  AMIK  
CONS[2]  2  1  2  2    2   1  2  
Ecoli[2]   1   2  1  1    1  2  
Klebsiella[3]   1   1       1  
NFGNB[6]   2  2  3   1    1  3  
St.aureus[2]    1  1    2   1   
Citrobacter[1]    1  1   1      
Beta 
Hemolytic  
Streptococci[7
]  
3   2  4  3   3  5  1   
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BACTERIOLOGICAL PROFILE OF THROAT CULTURE   
Beta hemolytic streptococci is the most common organism 
isolated (30.43%) followed by NFGNB (26.08%), E.coli, CONS and 
staph aureus. 
Beta hemolytic streptococci is highly susceptible to 
erythromycin (71.42%) followed by ciprofloxacin (57.14%). 
Ampicillin is also effective against it (42.85%). 
NFGNB is the next common organism isolated. It is equally 
sensitive to amikacin and ciprofloxacin (50%) followed by 
genatamicin and doxycycline (33.33%). 
Klebsiella in throat culture is highly resistant to all antibiotics. It 
is moderately sensitive to amikacin, ciprofloxacin and gentamicin 
(33.33%).             
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PUS CULTURE AND SENSITIVITY PATTERNS  
Total number of positive samples -18 
ORGANISMS AMP GM ERY CIP  CEF NOR CLOX CEPH  CEFTRI  AMIK 
CONS[7]  2  1  2  6  2   5  4  2  5  
Klebsiella[1]   1   1      1  1  
NFGNB[1]   1  1 1 1   1 1 
St.aureus[4]    1  1    2   1   
Pseudomonas[4]   2   2    2   1  2  
Proteus[1]   1     1    1  1  
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BACTERIOLOGICAL PROFILE OF PUS CULTURE   
 CONS is the predominant organism grown in pus. It is highly 
sensitive to ciprofloxacin (85.71%), cloxacillin (71.42%) and amikacin 
(71.42%). Cephalexin is also effective (57.14%). 
Staph aureus and pseudomonas are the other common organisms 
isolated from pus. Staph aureus is sensitive to cloxacillin (50%) than 
cephalosporins and erythromycin. Pseudomonas is sensitive to 
gentamicin and ciprofloxacin (50%).        
Proteus, klebsiella and NFGNB are the other common organisms 
grown in pus.    
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MOTION 
 
y Total samples-9 
y Negative -5 
Culture +ve-4 
y Shigella -3 
y K.oxytoca-1 
 
MOTION CULTURE AND SENSITIVITY PATTERN 
Total Positive Samples – 4 
Organisms  AMP  GM  CO CIP CEF NOR NA CEPH  CEFTRI AMIK  
Shigella (3)  2  3  1  2 2 2 
Klebsiella 
(1) 
   1  1    1 
 
Shigella is the predominant organism (75%) in motion. It is highly 
sensitive to Ciprofloxacin (100%), Gentamicin and Amikacin 
(66.66%). 
CSF culture  
CSF culture was taken from eight suspected cases of meningitis, 
(Headache, altered sensorium) but all proved to be culture negative. 
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SENSITIVE PATTERNS OF COMMON ORGANISMS 
ISOLATED FROM DIFFERENT SITES  
 In 5 cases simultaneous cultures from skin infection, blood and 
urine were taken. Of these no cases had same organisms grown from 
all 3 sites.  
 Simultaneous blood, urine culture was done in 59 cases. Of these 
six cases had same organisms grown in blood and urine.  
This implies that multiple infection is common in leukemics. A 
total of 19 organisms were resistant to all the common antibiotics. 
Staph aureus (5), klebsiella (4), NFGNB (4), pseudomonas                 
(3) E.coli (2), CONS (1) are the organisms distribution for these 19 
resistant bacteria.  
From the above data which was collected, the sensitivity pattern 
of the same organisms isolated from different sites were analysed.  
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CONS SENSITIVITY PATTERN 
 
 
 
 
 
 
 
 
SAMPLE  AMP  GM  ERY CIP  CEF  NOR  CLOX CEPH CEFTRI AMIK 
Blood [34]  5 20 7 24 12 2 29 11 27 21 
Urine[4]  1 2 - 3 - 1 2 - 2 2 
Throat[2]  2 1 2 2 - - 2 - 1 2 
Pus[7]  2 1 2 6 2 - 5 4 2 5 
Total (47) 10 24 11 35 14 3 38 15 32 30 
Percentage 21.27 51.06 23.40 74.46 29.78 6.38 80.85 31.91 68.08 63.82 
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E.COLI  SENSITIVITY PATTERN 
 
SAMPLE  AMP GM  DO  CIP  CEF  NOR  CLOX CEPH CEFTRI AMIK 
Blood [3]  - 1 - 3  2 - - 3 3 
Urine[27]  1 18 3 23 4 8 2 2 14 20 
Throat[2]  - 1  - 2  1  1  - - 1  2  
Motion(3) - 2  - 3  - 1  - 2  2  2  
Total (35) 1 22 3 31 5 12 2 4 20 27 
Percentage 2.85 62.85 8.57 88.57 14.28 34.28 5.71 1.14 57.14 77.14 
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KLEBSIELLA SENSITIVITY PATTERN 
 
SAMPLE AMP GM DO CIP CEF NOR CLOX CEPH CEFTRI AMIK 
Blood [5]  1 2  2 1 - - 1 1 3 
Urine [22]  1 15 4 19 2 5 2 3 4 17 
Throat [3]  - 1 - 1 - - - - - 1 
Pus [1]  - 1 - 1 - - - - 1 1 
Motion(1) - - - 1 - 1 - - - 1 
Total (32) 2 19 4 24 3 6 2 4 5 23 
Percentage  6.25 59.37 12.5 75 9.37 18.75 6.25 12.5 15.62 71.87 
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NFGNB SENSITIVITY PATTERN 
 
SAMPLE  AMP  GM  DO  CIP  CEF  NOR  CLOX CEPH CEFTRI AMIK 
Blood (9)  - 3 - 4 - 1 - - 1 6 
Urine  (11) - 2 2 7 2 6 - 1 3 8 
Throat (6) - 2 2 3  1 - - 1 3 
Pus (1) - 1 - 1 1 1 - - 1 1 
Total (27) - 8 4 15 3 9 - 1 6 18 
Percentage  - 29.62 14.81 55.55 11.11 33.33 - 3.7 22.22 66.66 
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STAPHYLOCOCCUS  AUREUS SENSITIVITY PATTERN 
 
SAMPLE  AMP GM ERY CIP CEF NOR  CLOX CEPH CEFTRI AMIK 
Blood [10]   1  4 1 1 6 1 1 3 
Throat  [2]    1  1    2   1   
Pus[4]    1  1    2   1   
Total (16)  1 2 6 1 1 10 1 3 3 
Percentage  6.25 12.5 37.5 6.25 6.25 62.5 6.25 18.75 18.75 
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PSEUDOMONAS SENSITIVITY PATTERN 
 
 
SAMPLE  AMP GM DO CIP CEF NOR  CLOX CEPH CEFTRI AMIK 
Blood [6]  - 2 - 3 - - 2 - - 4 
Pus[4]  - 2 - 2 - - 2 - 1 2 
Total (10) - 4 - 5 - - 4 - 1 6 
Percentage - 40 - 50 - - 40 - 10 60 
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DISCUSSION 
 
CONS is the predominant organism isolated from our study 
while staph aureus and mycobacteria are the common organisms from 
Gopalnath study1.    
CONS is usually resistant to many antibiotic as per the study of 
Gopinath et al but in our study it is highly susceptible to common 
antibiotics. 
The other commonest organism isolated were staph aureus, 
E.coli, klebsiella in both the studies.  
Antibiotics chosen for empirical therapy of episodes of febrile 
neutropenia must be active against the majority of Gram-negative 
pathogens, as these bacteria are associated with high mortality. 
However, with the emergence of viridans streptococci as significant 
pathogens in immunocompromised patients, the ideal empirical 
regimen should also have activity against these organisms22. 
In our study CONS is the predominant organism in blood, e.coli 
and klebsiella in urine. This is similar to Srivastava et al18 study where 
gram-negative bacteria causing UTI were mainly Escherichia 
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coli and Klebsiella pneumoniae, while gram-negative bacteria 
causing RTI were mainly Klebsiella pneumonia. 
Ashour et al also reported the evolution of imipenem-
resistant gram-negative strains in Egypt. Mortality rates were higher in 
leukemic patients with nosocomial Pseudomonas infections than any 
other bacterial infections. Policies restricting antibiotic consumption 
should be implemented to avoid the evolution of newer generations of 
antibiotic resistant-pathogens. 
Similar reports from sheriff et al is that skin infections and blood 
stream infections were mainly Coagulase-negative staphylococcus 
(CONS) and S. aureus, whereas  bacteria causing throat and respiratory 
infections were mainly alpha-hemolytic streptococci and CONS.  
Our study shows CONS as highly sensitive and s.aureus and 
klebsiella as resistant bacteria against the common antibiotics but 
sheriff reported vancomycin- and linezolid-resistant S. aureus in 
Egypt.and Newer generation quinolones (moxifloxacin and 
gatifloxacin) were more active than older quinolones (ciprofloxacin 
and ofloxacin) against S. aureus and CNS, suggesting the use of newer 
generation quinolones in the prophylaxis of cancer patients. 
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 Gopalnath et al1 had done study in North East Indian population 
where ciprofloxacin resistance is very common. But in our study 
ciprofloxacin is the most effective antibiotic for gram negative 
infections and next to cloxacillin for gram positive infections. 
 Majority of gram negative isolates (E.coli, klebsiella) are 
sensitive to amikacin in both studies staph aureus is resistant to 
amikacin but sensitive to cloxacillin unlike Gopalnath’s study similar 
suggestions were made by previous investigations also24,25.   
 Streptococcus viridans, staph aureus, E.coli, klebsiella are the 
common organisms from Deepa Anirudhan et al29 study but Group B 
streptococcus, NFGNB are common isolates of our study.    
 
 
 
 
 
 
 
54 
 
LIMITATIONS 
1. Viral, fungal, anaerobic and some bacteria which require special 
media cannot be isolated in this study due to limited resources.  
2. Newer antibiotics susceptibility were not included in this study 
due to financial constraints.   
3. Correlation between type of organisms with stage of 
chemotherapy and blood counts could not be ascertained.  
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CONCLUSION 
1. Leukemic children are more prone to various infections due to poor 
immunity. The predominant micro organisms in leukemic patients 
are : 
a. coagulase negative staphylococcus aureus in blood.  
b. E.Coli and Klebsiella in urine 
c. Beta hemolytic streptococci  and non fermentative gram 
negative bacilli in throat swab.  
d. CONS, Staphylococcus aureus and pseudomonas in pus. 
e. Klebsiella, Shigella (NFGNB) in motion. 
2. Susceptibility of organisms to antibiotic is nearly similar 
irrespective of the source of isolation. 
3. From the sensitive pattern of organisms studied CONS is highly 
susceptible to cloxacillin and ciprofloxacin. E.coli is susceptible to 
amikacin and ciprofloxacin. Klebsiella is relatively resistant to our 
common antibiotics and sensitive to ciprofloxacin and amikacin. 
NFGNB is more resistant organism and sensitive to amikacin and 
ciprofloxacin. Staphylococcus aureus is sensitive to cloxacillin. 
Pseudomonas is sensitive to amikacin and ciprofloxacin.  
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4. The incidence of multi drug resistant organisms in leukemics is 
common in leukemic patients (mainly Staphylococcus aureus, 
NFGNB and klebsiella).   
5. The highest isolation of CONS E.coli, Klebsiella pneumonia, 
Non fermentative gram negative bacilli, S. aureus, and 
Pseudomonas aeruginosa indicates that special attention should 
be given to these bacteria during treatment when there is any 
febrile episode in leukemia patients.  
6. Some of the patients where no pathogen could be detected may 
have some anaerobic bacteria for which special efforts should be 
made. 
7. Ciprofloxacin is the universal antibiotic active against both gram 
positive and negative bacteria.  
8. Amikacin / gentamicin is more effective than ceftriaxone for 
gram negative infections. Cloxacillin is the most effective 
antibiotic for gram positive infections.  
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RECOMMENDATIONS 
1. Strict aseptic precautions should be adhered while examining 
them or doing procedures as they are highly vulnerable to 
infections. 
2. Separate ward with air fitters with frequent fumigation in 
essential  
3. Antibiotic treatment should be entirely based on culture & 
sensitivity reports. 
4. Empirical treatment is preferably avoided for fear of multidrug 
resistance, antibiotic failure / irriationale use and drug induced 
complications. 
5. In case of resource poor settings if at all empirical treatment 
should be started then a combination of cloxacillin (for gram 
positive organisms) and amikacin / ciprofloxacin has to be 
started.   
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1 Boopathi 5 M 35216 Y N N N N N N N Y N + + ‐ ‐ ‐ ‐ B,U C K ‐ ‐ ‐ ‐
2 Balakrishnan 8 M 36238 Y N N N N N N N Y N + + ‐ ‐ ‐ ‐ B,U C N ‐ ‐ ‐ ‐
3 Mounaselvaraj 7 M 23412 Y N Y N N N N Y Y N + + ‐ ‐ ‐ ‐ B,U E NG ‐ ‐ ‐ ‐
4 Santhoshkumar 9 M 12421 Y N Y N N Y Y N N N + ‐ + ‐ ‐ ‐ B,T S ‐ B ‐ ‐ ‐
5 Manikandan 4 M 26721 Y N N N N N N N N N ‐ ‐ + ‐ ‐ ‐ T ‐ ‐ C ‐ ‐ ‐
6 Veeramani 6 M 34216 Y N N Y Y N N Y Y N ‐ ‐ + + ‐ + T,S ‐ ‐ N ‐ NG
7 Sneha 4 F 12416 Y Y Y Y Y N Y N N N + + ‐ + ‐ ‐ S NG NG ‐ S ‐ ‐
8 Prithivi 7 M 32165 Y N N N N N N N N N + + ‐ ‐ ‐ ‐ B,U C E ‐ ‐ ‐ ‐
9 Karuppasamy 6 M 42861 Y N N Y Y N N N N Y + ‐ ‐ ‐ + ‐ B,M C ‐ ‐ ‐ NG ‐
10 Praveen 10 M 68216 Y N N Y Y N N N N N + ‐ ‐ + + ‐ S,T ‐ ‐ N C ‐ ‐
11 Avinash 6 M 52136 Y N N Y Y N Y N N N + + + + ‐ ‐ B,T, S C NG N P ‐ ‐
12 Sivadharani 4 M 48216 Y N Y N N N N N N N + + ‐ ‐ ‐ + B,U C E ‐ ‐ ‐ NG
13 Rabiya 6 F 56142 Y N N N N N Y N N Y + + ‐ ‐ + B,T P ‐ B ‐ SH ‐
14 Balamurugan 8 M 63126 Y N Y N N N N N N N ‐ ‐ + ‐ ‐ ‐ T ‐ ‐ N ‐ ‐ ‐
15 Sakthivel 9 M 62111 Y N N Y Y N N Y N N + + ‐ + ‐ ‐ B,U,S C E ‐ C ‐ ‐
16 Logesh 4 M 44526 Y N N Y Y N Y N N N + + + ‐ ‐ ‐ NG NG ‐ ‐ ‐ ‐
17 Karuppasamy 8 M 48261 N N Y Y Y N Y N N N + + ‐ + ‐ ‐ B,U,S S K ‐ C ‐ ‐
18 Lokesh 5 M 43216 Y N N N N N N N N N + + ‐ ‐ ‐ ‐ NG NG ‐ ‐ ‐ ‐
19 Santhosh 6 M 55216 Y N Y N N N N Y N Y + + ‐ ‐ + + B,U,M,R S ‐ ‐ ‐ SH NG
20 Karuppasamy 4 M 23125 Y N N N N N N N N N ‐ ‐ + + ‐ ‐ S.T ‐ ‐ B S ‐ ‐
21 Avinash 6 M 52678 Y N N Y Y N Y Y N N + + + ‐ ‐ ‐ T ‐ NG N ‐ ‐ ‐
22 Lokesh 5 M 58241 N Y Y N N N N N N N + + ‐ ‐ ‐ ‐ U NG E ‐ ‐ ‐ ‐
23 Nivedha 6 F 57216 Y Y N N N N N Y N N + + ‐ ‐ ‐ ‐ B,U E NG ‐ ‐ ‐ ‐
24 Shiva 5 M 50129 Y N Y N N N Y N N N + + ‐ ‐ ‐ ‐ U NG K ‐ ‐ ‐ ‐
25 Koodalingam 10 M 51738 Y N N Y Y Y N N N N + + ‐ ‐ ‐ + B K NG ‐ ‐ ‐ NG
26 Lokesh 5 M 53487 Y N Y N N N Y N N N + + ‐ + ‐ ‐ S NG C ‐ C ‐ ‐
27 Santhosh 6 M 65297 Y Y N N N N Y N N Y + + ‐ ‐ + ‐ B C ‐ ‐ ‐ NG ‐
28 Agalya 5 F 63712 N N N Y Y N Y N N N ‐ ‐ + ‐ ‐ ‐ T ‐ C C ‐ ‐ ‐
29 Siva 5 M 65129 Y N N N N N N N N N + ‐ ‐ ‐ ‐ ‐ B C NG ‐ ‐ ‐ ‐
30 Karuppasamy 8 M 67839 Y N N N N N N N N N + + ‐ ‐ ‐ ‐ U NG C ‐ ‐ ‐ ‐
31 Sivadharani 5 F 64196 N N N Y Y N Y N N N + + ‐ + ‐ ‐ B,U,S C ‐ ‐ C ‐ ‐
32 Nishanthi 4 F 69127 Y N N N N N N N N N ‐ ‐ + ‐ ‐ ‐ T ‐ ‐ B ‐ ‐ ‐
33 Jegadeesh 7 M 76921 N Y N Y Y N Y N N N ‐ + ‐ ‐ ‐ + U ‐ NG ‐ ‐ ‐ NG
34 Nivetha 6 F 74262 Y N N N N N N Y N Y ‐ + ‐ ‐ + ‐ B,M NG NG ‐ ‐ K ‐
SYMPTOMS SOURCE OF SAMPLE COLLECTED ORGANISM ISOLATED
Positive 
Growth
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SYMPTOMS SOURCE OF SAMPLE COLLECTED ORGANISM ISOLATED
Positive 
Growth
35 Koodalingam 10 M 72164 N N N N N N Y N N N + + ‐ + ‐ ‐ S NG C ‐ P ‐ ‐
36 Santhosh 8 M 78412 Y N N Y Y N N N N N + + ‐ ‐ ‐ ‐ B,U C ‐ ‐ ‐ ‐ ‐
37 Siva 7 M 77216 N N N N N N N N N N ‐ + + ‐ ‐ ‐ U,T ‐ C B ‐ ‐ ‐
38 Sneha 6 F 73412 Y N N N N N Y N N N + + ‐ ‐ ‐ ‐ B,U C ‐ ‐ ‐ ‐ ‐
39 Nandhini 4 F 79412 Y N N N N N N Y N N ‐ ‐ ‐ + + + S ‐ ‐ ‐ C NG NG
40 Santhosh Kumar 11 M 78627 N Y N Y Y N Y N N Y ‐ + ‐ + ‐ ‐ ‐ C ‐ ‐ ‐ ‐
41 Rajavarshika 4 M 77428 Y N N N N N N N N N + + ‐ ‐ ‐ ‐ B,U C NG ‐ ‐ ‐ ‐
42 Naveen Raja 10 M 76421 N N N N N N N N N N + + ‐ ‐ ‐ ‐ NG NG ‐ ‐ ‐ ‐
43 Chandrasekar 12 M 71426 Y N N Y Y N N N N N + ‐ + ‐ ‐ ‐ B,T N ‐ N ‐ ‐ ‐
44 Veeramani 6 M 73489 Y N N Y Y N Y N N N + ‐ + ‐ ‐ ‐ T NG ‐ C ‐ ‐ ‐
45 Boomiraj 11 M 72162 Y N N N N N N N N N + ‐ ‐ + ‐ ‐ B,T,S C E E S ‐ ‐
46 Balakrishnan 10 M 74126 Y N N N N N Y N N N + + ‐ ‐ ‐ ‐ B C K ‐ ‐ ‐ ‐
47 Vishwabarathi 9 M 75138 N Y N N N N N N N N ‐ + + ‐ ‐ ‐ U ‐ ‐ ‐ ‐ ‐ ‐
48 Praveen 6 M 79216 Y Y N N N N Y N N N + ‐ ‐ ‐ ‐ ‐ B,U,T E E N ‐ ‐ ‐
49 Martin vijay 10 M 78123 Y N N N N N N N N Y + + ‐ + + ‐ B,S,M K K ‐ C SH
50 Vignesh 6 M 77489 N Y N N N N Y N N N ‐ + + ‐ ‐ ‐ U ‐ NG ‐ ‐ ‐ ‐
51 Pappammal 6 F 76279 Y Y Y Y Y N Y N N N + + + ‐ ‐ + B,U,T E ‐ B ‐ ‐ NG
52 Sneha 4 F 79218 Y N N Y Y N N N N N + ‐ ‐ ‐ ‐ ‐ B,U,T K N E ‐ ‐ ‐
53 Ajith 11 M 77421 Y N N N N N Y N N N + + ‐ ‐ ‐ ‐ B NG NG ‐ ‐ ‐ ‐
54 Akalya 4 F 79826 N N N N N N Y N N Y + + ‐ + + ‐ B,U,S C K ‐ C NG ‐
55 Sivadharani 5 F 84216 Y Y N N N N N N N N + ‐ + ‐ ‐ ‐ B N N ‐ ‐ ‐ ‐
56 Nisha 3 F 87839 Y Y N Y Y N N N N N + + ‐ ‐ ‐ ‐ B,U NG E C ‐ ‐ ‐
57 Sivadharani 4 F 82126 Y N N Y Y N N N N N + + + + ‐ + B,U ‐ K ‐ P ‐ NG
58 Abi 2 F 62164 Y N N N N N Y N N N + + ‐ ‐ ‐ ‐ B,T N E B ‐ ‐ ‐
59 Riyaz Ahmad 11 M 85412 Y N N N N N N N N N + + ‐ ‐ ‐ ‐ B,U,S E N ‐ ‐ ‐ ‐
60 Vignesh 9 M 72142 Y N N N N N Y N N N + + ‐ ‐ ‐ ‐ B,U,T K E ‐ ‐ ‐ ‐
61 Priya 4 F 34216 Y N N N N N N N N N + + ‐ + ‐ ‐ B,U E E ‐ C ‐ ‐
62 Gopiprasath 10 M 54213 Y N N N N N Y N N N + + ‐ ‐ ‐ ‐ B,U N ‐ ‐ ‐ ‐ ‐
63 Simran 5 F 46212 Y N N N N N N N N N + + ‐ ‐ ‐ ‐ B,U,S E K ‐ ‐ ‐ ‐
64 Kowsalya 4 F 64126 Y Y N N N N Y N N N + + ‐ ‐ ‐ ‐ B,U E ‐ ‐ ‐ ‐
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